Research & development increased 109.7%
Research & development changed +109.7% from the comparable as-filed period.
$185,000→$388,0003 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TCRT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding increased 15.7%
Shares outstanding changed +15.7% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
2,194,941→2,540,4808 prior comparisons
Stock-based compensation increased 33.7%
Stock-based compensation changed +33.7% from the comparable as-filed period.
$184,000→$246,0003 prior comparisons
Operating income increased 8.4%
Operating income changed +8.4% from the comparable as-filed period.
-$1.0M→-$952,0003 prior comparisons
Net income increased 9.4%
Net income changed +9.4% from the comparable as-filed period.
-$1.1M→-$952,0002 prior comparisons
Working capital changed across a sign change
Working capital changed -107.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$2.7M→-$198,0004 prior comparisons
Current liabilities decreased 19.6%
Current liabilities changed -19.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.1M→$864,0004 prior comparisons
Revenue changed across a zero base
Revenue changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$03 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.